New guidelines suggest that for most asthma patients a single inhaler strategy with both an ICS and a quick onset LABA can be used for maintenance and rescue therapy. This has been shown to improve symptoms and decrease need for health care visits. But what is the latest data on SMART therapy and what are the barriers to its use?

The GameChanger: SMART therapy should be the standard of care for most asthma patients.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Reference
Meta-analysis
https://pubmed.ncbi.nlm.nih.gov/35230437/

Asthma Action Plan
Do You Have an Asthma Action Plan?

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the latest information concerning SMART therapy in asthma.
2. Discuss how healthcare workers can decrease barriers and increase acces to SMART therapy.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-165-H01-P
Initial release date: 05/06/2024
Expiration date: 05/06/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram